Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,628
archived clinical trials in
Schizophrenia

Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder
A Parallel-arm, Double-blind, Placebo and Positive Controlled Multiple Oral Dose Administration Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated:  9/29/2015
Otsuka Investigational Site
mi
from
San Diego, CA
Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder
A Parallel-arm, Double-blind, Placebo and Positive Controlled Multiple Oral Dose Administration Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated: 9/29/2015
Otsuka Investigational Site
mi
from
San Diego, CA
Click here to add this to my saved trials
Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder
A Parallel-arm, Double-blind, Placebo and Positive Controlled Multiple Oral Dose Administration Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated:  9/29/2015
Otsuka Investigational Site
mi
from
Fort Lauderdale, FL
Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder
A Parallel-arm, Double-blind, Placebo and Positive Controlled Multiple Oral Dose Administration Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated: 9/29/2015
Otsuka Investigational Site
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder
A Parallel-arm, Double-blind, Placebo and Positive Controlled Multiple Oral Dose Administration Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated:  9/29/2015
Otsuka Investigational Site
mi
from
Overland Park, KA
Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder
A Parallel-arm, Double-blind, Placebo and Positive Controlled Multiple Oral Dose Administration Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated: 9/29/2015
Otsuka Investigational Site
mi
from
Overland Park, KA
Click here to add this to my saved trials
Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder
A Parallel-arm, Double-blind, Placebo and Positive Controlled Multiple Oral Dose Administration Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated:  9/29/2015
Otsuka Investigational Site
mi
from
Rockville, MD
Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder
A Parallel-arm, Double-blind, Placebo and Positive Controlled Multiple Oral Dose Administration Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated: 9/29/2015
Otsuka Investigational Site
mi
from
Rockville, MD
Click here to add this to my saved trials
Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder
A Parallel-arm, Double-blind, Placebo and Positive Controlled Multiple Oral Dose Administration Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated:  9/29/2015
Otsuka Investigational Site
mi
from
St. Louis, MO
Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder
A Parallel-arm, Double-blind, Placebo and Positive Controlled Multiple Oral Dose Administration Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated: 9/29/2015
Otsuka Investigational Site
mi
from
St. Louis, MO
Click here to add this to my saved trials
Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder
A Parallel-arm, Double-blind, Placebo and Positive Controlled Multiple Oral Dose Administration Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated:  9/29/2015
Otsuka Investigational Site
mi
from
Philadelphia, PA
Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder
A Parallel-arm, Double-blind, Placebo and Positive Controlled Multiple Oral Dose Administration Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated: 9/29/2015
Otsuka Investigational Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder
A Parallel-arm, Double-blind, Placebo and Positive Controlled Multiple Oral Dose Administration Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated:  9/29/2015
Otsuka Investigational Site
mi
from
Austin, TX
Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder
A Parallel-arm, Double-blind, Placebo and Positive Controlled Multiple Oral Dose Administration Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated: 9/29/2015
Otsuka Investigational Site
mi
from
Austin, TX
Click here to add this to my saved trials
Multicenter, Open-label, Safety and Tolerability Study
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Monotherapy in Adult Patients With Schizophrenia
Status: Enrolling
Updated:  9/29/2015
Otsuka Investigational Site
mi
from
Little Rock, AR
Multicenter, Open-label, Safety and Tolerability Study
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Monotherapy in Adult Patients With Schizophrenia
Status: Enrolling
Updated: 9/29/2015
Otsuka Investigational Site
mi
from
Little Rock, AR
Click here to add this to my saved trials
Multicenter, Open-label, Safety and Tolerability Study
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Monotherapy in Adult Patients With Schizophrenia
Status: Enrolling
Updated:  9/29/2015
Otsuka Investigational Site
mi
from
Escondido, CA
Multicenter, Open-label, Safety and Tolerability Study
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Monotherapy in Adult Patients With Schizophrenia
Status: Enrolling
Updated: 9/29/2015
Otsuka Investigational Site
mi
from
Escondido, CA
Click here to add this to my saved trials
Multicenter, Open-label, Safety and Tolerability Study
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Monotherapy in Adult Patients With Schizophrenia
Status: Enrolling
Updated:  9/29/2015
Otsuka Investigational Site
mi
from
Garden Grove, CA
Multicenter, Open-label, Safety and Tolerability Study
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Monotherapy in Adult Patients With Schizophrenia
Status: Enrolling
Updated: 9/29/2015
Otsuka Investigational Site
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Multicenter, Open-label, Safety and Tolerability Study
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Monotherapy in Adult Patients With Schizophrenia
Status: Enrolling
Updated:  9/29/2015
Otsuka Investigational Site
mi
from
Long Beach, CA
Multicenter, Open-label, Safety and Tolerability Study
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Monotherapy in Adult Patients With Schizophrenia
Status: Enrolling
Updated: 9/29/2015
Otsuka Investigational Site
mi
from
Long Beach, CA
Click here to add this to my saved trials
Multicenter, Open-label, Safety and Tolerability Study
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Monotherapy in Adult Patients With Schizophrenia
Status: Enrolling
Updated:  9/29/2015
Otsuka Investigational Site
mi
from
Oceanside, CA
Multicenter, Open-label, Safety and Tolerability Study
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Monotherapy in Adult Patients With Schizophrenia
Status: Enrolling
Updated: 9/29/2015
Otsuka Investigational Site
mi
from
Oceanside, CA
Click here to add this to my saved trials
Multicenter, Open-label, Safety and Tolerability Study
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Monotherapy in Adult Patients With Schizophrenia
Status: Enrolling
Updated:  9/29/2015
Otsuka Investigational Site
mi
from
Pasadena, CA
Multicenter, Open-label, Safety and Tolerability Study
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Monotherapy in Adult Patients With Schizophrenia
Status: Enrolling
Updated: 9/29/2015
Otsuka Investigational Site
mi
from
Pasadena, CA
Click here to add this to my saved trials
Multicenter, Open-label, Safety and Tolerability Study
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Monotherapy in Adult Patients With Schizophrenia
Status: Enrolling
Updated:  9/29/2015
Otsuka Investigational Site
mi
from
San Diego, CA
Multicenter, Open-label, Safety and Tolerability Study
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Monotherapy in Adult Patients With Schizophrenia
Status: Enrolling
Updated: 9/29/2015
Otsuka Investigational Site
mi
from
San Diego, CA
Click here to add this to my saved trials
Multicenter, Open-label, Safety and Tolerability Study
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Monotherapy in Adult Patients With Schizophrenia
Status: Enrolling
Updated:  9/29/2015
Otsuka Investigational Site
mi
from
Santa Ana, CA
Multicenter, Open-label, Safety and Tolerability Study
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Monotherapy in Adult Patients With Schizophrenia
Status: Enrolling
Updated: 9/29/2015
Otsuka Investigational Site
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Multicenter, Open-label, Safety and Tolerability Study
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Monotherapy in Adult Patients With Schizophrenia
Status: Enrolling
Updated:  9/29/2015
Otsuka Investigational Site
mi
from
Washington,
Multicenter, Open-label, Safety and Tolerability Study
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Monotherapy in Adult Patients With Schizophrenia
Status: Enrolling
Updated: 9/29/2015
Otsuka Investigational Site
mi
from
Washington,
Click here to add this to my saved trials
Multicenter, Open-label, Safety and Tolerability Study
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Monotherapy in Adult Patients With Schizophrenia
Status: Enrolling
Updated:  9/29/2015
Otsuka Investigational Site
mi
from
Bradenton, FL
Multicenter, Open-label, Safety and Tolerability Study
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Monotherapy in Adult Patients With Schizophrenia
Status: Enrolling
Updated: 9/29/2015
Otsuka Investigational Site
mi
from
Bradenton, FL
Click here to add this to my saved trials
Multicenter, Open-label, Safety and Tolerability Study
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Monotherapy in Adult Patients With Schizophrenia
Status: Enrolling
Updated:  9/29/2015
Otsuka Investigational Site
mi
from
Maitland, FL
Multicenter, Open-label, Safety and Tolerability Study
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Monotherapy in Adult Patients With Schizophrenia
Status: Enrolling
Updated: 9/29/2015
Otsuka Investigational Site
mi
from
Maitland, FL
Click here to add this to my saved trials
Multicenter, Open-label, Safety and Tolerability Study
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Monotherapy in Adult Patients With Schizophrenia
Status: Enrolling
Updated:  9/29/2015
Otsuka Investigational Site
mi
from
St. Louis, MO
Multicenter, Open-label, Safety and Tolerability Study
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Monotherapy in Adult Patients With Schizophrenia
Status: Enrolling
Updated: 9/29/2015
Otsuka Investigational Site
mi
from
St. Louis, MO
Click here to add this to my saved trials
Multicenter, Open-label, Safety and Tolerability Study
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Monotherapy in Adult Patients With Schizophrenia
Status: Enrolling
Updated:  9/29/2015
Otsuka Investigational Site
mi
from
Cedarhurst, NY
Multicenter, Open-label, Safety and Tolerability Study
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Monotherapy in Adult Patients With Schizophrenia
Status: Enrolling
Updated: 9/29/2015
Otsuka Investigational Site
mi
from
Cedarhurst, NY
Click here to add this to my saved trials
Multicenter, Open-label, Safety and Tolerability Study
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Monotherapy in Adult Patients With Schizophrenia
Status: Enrolling
Updated:  9/29/2015
Otsuka Investigational Site
mi
from
Philadelphia, PA
Multicenter, Open-label, Safety and Tolerability Study
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Monotherapy in Adult Patients With Schizophrenia
Status: Enrolling
Updated: 9/29/2015
Otsuka Investigational Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Multicenter, Open-label, Safety and Tolerability Study
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Monotherapy in Adult Patients With Schizophrenia
Status: Enrolling
Updated:  9/29/2015
Otsuka Investigational Site
mi
from
Austin, TX
Multicenter, Open-label, Safety and Tolerability Study
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Monotherapy in Adult Patients With Schizophrenia
Status: Enrolling
Updated: 9/29/2015
Otsuka Investigational Site
mi
from
Austin, TX
Click here to add this to my saved trials
Multicenter, Open-label, Safety and Tolerability Study
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Monotherapy in Adult Patients With Schizophrenia
Status: Enrolling
Updated:  9/29/2015
Otsuka Investigational Site
mi
from
Burgas,
Multicenter, Open-label, Safety and Tolerability Study
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Monotherapy in Adult Patients With Schizophrenia
Status: Enrolling
Updated: 9/29/2015
Otsuka Investigational Site
mi
from
Burgas,
Click here to add this to my saved trials
Contingent Incentives Plus Bupropion for Smoking in People With Schizophrenia
Incentives Plus Bupropion for Smoking in Schizophrenics
Status: Enrolling
Updated:  10/5/2015
Brown University
mi
from
Providence, RI
Contingent Incentives Plus Bupropion for Smoking in People With Schizophrenia
Incentives Plus Bupropion for Smoking in Schizophrenics
Status: Enrolling
Updated: 10/5/2015
Brown University
mi
from
Providence, RI
Click here to add this to my saved trials
Targeted Vitamin D Treatment of Schizophrenia-Associated Hyperprolinemia
Vitamin-D Treatment Targeted to Hyperprolinemia-Associated Schizophrenia.
Status: Enrolling
Updated:  10/7/2015
Bellevue Hospital Center
mi
from
New York, NY
Targeted Vitamin D Treatment of Schizophrenia-Associated Hyperprolinemia
Vitamin-D Treatment Targeted to Hyperprolinemia-Associated Schizophrenia.
Status: Enrolling
Updated: 10/7/2015
Bellevue Hospital Center
mi
from
New York, NY
Click here to add this to my saved trials
Pregnenolone for Cognitive and Negative Symptoms in Schizophrenia
Pregnenolone for Cognitive and Negative Symptoms in Schizophrenia
Status: Enrolling
Updated:  10/13/2015
Durham VA Medical Center, Durham, NC
mi
from
Durham, NC
Pregnenolone for Cognitive and Negative Symptoms in Schizophrenia
Pregnenolone for Cognitive and Negative Symptoms in Schizophrenia
Status: Enrolling
Updated: 10/13/2015
Durham VA Medical Center, Durham, NC
mi
from
Durham, NC
Click here to add this to my saved trials
Early Detection and Intervention for the Prevention of Psychosis
Early Detection and Intervention for the Prevention of Psychosis Project
Status: Enrolling
Updated:  10/22/2015
University of California-Davis, Imaging Research Center
mi
from
Sacramento, CA
Early Detection and Intervention for the Prevention of Psychosis
Early Detection and Intervention for the Prevention of Psychosis Project
Status: Enrolling
Updated: 10/22/2015
University of California-Davis, Imaging Research Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Early Detection and Intervention for the Prevention of Psychosis
Early Detection and Intervention for the Prevention of Psychosis Project
Status: Enrolling
Updated:  10/22/2015
Portland Identification and Early Referral Program
mi
from
Portland, ME
Early Detection and Intervention for the Prevention of Psychosis
Early Detection and Intervention for the Prevention of Psychosis Project
Status: Enrolling
Updated: 10/22/2015
Portland Identification and Early Referral Program
mi
from
Portland, ME
Click here to add this to my saved trials
Early Detection and Intervention for the Prevention of Psychosis
Early Detection and Intervention for the Prevention of Psychosis Project
Status: Enrolling
Updated:  10/22/2015
Washtenaw County
mi
from
Ann Arbor, MI
Early Detection and Intervention for the Prevention of Psychosis
Early Detection and Intervention for the Prevention of Psychosis Project
Status: Enrolling
Updated: 10/22/2015
Washtenaw County
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Early Detection and Intervention for the Prevention of Psychosis
Early Detection and Intervention for the Prevention of Psychosis Project
Status: Enrolling
Updated:  10/22/2015
University of New Mexico
mi
from
Albuquerque, NM
Early Detection and Intervention for the Prevention of Psychosis
Early Detection and Intervention for the Prevention of Psychosis Project
Status: Enrolling
Updated: 10/22/2015
University of New Mexico
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Early Detection and Intervention for the Prevention of Psychosis
Early Detection and Intervention for the Prevention of Psychosis Project
Status: Enrolling
Updated:  10/22/2015
Zucker Hillside Hosptial
mi
from
Glen Oaks, NY
Early Detection and Intervention for the Prevention of Psychosis
Early Detection and Intervention for the Prevention of Psychosis Project
Status: Enrolling
Updated: 10/22/2015
Zucker Hillside Hosptial
mi
from
Glen Oaks, NY
Click here to add this to my saved trials
Early Detection and Intervention for the Prevention of Psychosis
Early Detection and Intervention for the Prevention of Psychosis Project
Status: Enrolling
Updated:  10/22/2015
Mid-Valley Behavioral Care Network
mi
from
Salem, OR
Early Detection and Intervention for the Prevention of Psychosis
Early Detection and Intervention for the Prevention of Psychosis Project
Status: Enrolling
Updated: 10/22/2015
Mid-Valley Behavioral Care Network
mi
from
Salem, OR
Click here to add this to my saved trials
Single-ascending Dose Study With a Food-Effect Cohort to Evaluate AMG 581
A Phase 1, Randomized, Double-blind, Placebo-controlled, Single-ascending Dose Study With a Food-Effect Cohort to Evaluate the Safety, Tolerability, and Pharmacokinetics of AMG 581 in Healthy Subjects and Subjects With Schizophrenia
Status: Enrolling
Updated:  10/22/2015
Clinical Research Facility
mi
from
Glendale, CA
Single-ascending Dose Study With a Food-Effect Cohort to Evaluate AMG 581
A Phase 1, Randomized, Double-blind, Placebo-controlled, Single-ascending Dose Study With a Food-Effect Cohort to Evaluate the Safety, Tolerability, and Pharmacokinetics of AMG 581 in Healthy Subjects and Subjects With Schizophrenia
Status: Enrolling
Updated: 10/22/2015
Clinical Research Facility
mi
from
Glendale, CA
Click here to add this to my saved trials
Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Fixed-dose OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Little Rock, AR
Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Fixed-dose OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Fixed-dose OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Springdale, AR
Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Fixed-dose OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Springdale, AR
Click here to add this to my saved trials
Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Fixed-dose OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Escondido, CA
Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Fixed-dose OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Escondido, CA
Click here to add this to my saved trials
Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Fixed-dose OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Long Beach, CA
Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Fixed-dose OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Long Beach, CA
Click here to add this to my saved trials
Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Fixed-dose OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Pico Rivera, CA
Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Fixed-dose OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Pico Rivera, CA
Click here to add this to my saved trials
Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Fixed-dose OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
San Diego, CA
Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Fixed-dose OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Fixed-dose OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
North Miami, FL
Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Fixed-dose OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
North Miami, FL
Click here to add this to my saved trials
Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Fixed-dose OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Lake Charles, LA
Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Fixed-dose OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Lake Charles, LA
Click here to add this to my saved trials
Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Fixed-dose OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Shreveport, LA
Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Fixed-dose OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Shreveport, LA
Click here to add this to my saved trials
Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Fixed-dose OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Flowood, MS
Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Fixed-dose OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Flowood, MS
Click here to add this to my saved trials
Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Fixed-dose OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
St. Louis, MO
Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Fixed-dose OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
St. Louis, MO
Click here to add this to my saved trials
Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Fixed-dose OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Buffalo, NY
Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Fixed-dose OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Buffalo, NY
Click here to add this to my saved trials
Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Fixed-dose OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Memphis, TN
Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Fixed-dose OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Fixed-dose OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Austin, TX
Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Fixed-dose OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Fixed-dose OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Dallas, TX
Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Fixed-dose OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Fixed-dose OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Houston, TX
Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Fixed-dose OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Fixed-dose OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Orange, CA
Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Fixed-dose OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Orange, CA
Click here to add this to my saved trials